Prevalence of and risk factors for severe cognitive and sleep symptoms in ME/CFS and MS.
Jain, Vageesh, Arunkumar, Amit, Kingdon, Caroline et al. · BMC neurology · 2017 · DOI
Quick Summary
This study compared cognitive problems (like trouble concentrating and memory issues) and sleep difficulties in people with ME/CFS and people with MS. Researchers found that cognitive and sleep problems were much more common in ME/CFS patients—98% reported trouble concentrating, and 55% reported severe unrefreshing sleep. The study also identified that ME/CFS patients who were older, current smokers, or had lower incomes were more likely to experience severe symptoms.
Why It Matters
Cognitive dysfunction and sleep problems are debilitating features of ME/CFS that significantly impact quality of life, yet little is known about risk factors for severe presentations. This study quantifies the burden of these symptoms in ME/CFS compared to other conditions and identifies vulnerable subgroups who may benefit from early intervention, informing potential therapeutic targets and patient stratification strategies.
Observed Findings
Trouble concentrating was reported by 98.3% of ME/CFS patients, the most prevalent cognitive symptom studied.
Severe unrefreshing sleep was reported by 55% of ME/CFS patients, more common than severe symptoms in the MS group.
All cognitive and sleep symptoms were more prevalent in ME/CFS patients compared to MS patients and healthy controls.
ME/CFS patients aged over 50 years had 3.2 times higher odds of severe symptoms than those under 30.
Current smoking was associated with approximately 3-fold increased odds of severe symptoms in ME/CFS patients.
Inferred Conclusions
Cognitive and sleep symptoms are core features of ME/CFS and more common/severe than in MS, suggesting central nervous system abnormalities specific to ME/CFS.
Older age, current smoking, and lower household income are characteristics of ME/CFS patients at highest risk for severe cognitive and sleep symptoms.
Early identification and intervention targeting modifiable risk factors (smoking) and vulnerable populations may help prevent symptom progression.
Remaining Questions
What are the underlying mechanisms linking smoking and low income to severe cognitive/sleep symptoms—are these causal or confounded by unmeasured factors?
What This Study Does Not Prove
This study cannot establish causal relationships between identified risk factors and severe symptoms—for example, it cannot prove that smoking causes severe cognitive symptoms, only that they are associated. The cross-sectional design means we cannot determine whether symptom severity changes over time or precedes/follows the identified risk factors. Results are also specific to this UK cohort and may not generalize to other populations.